These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7911579)

  • 21. Power spectrum analysis of ultrasonic vocalization elicited by maternal separation in rat pups.
    Ise S; Ohta H
    Brain Res; 2009 Aug; 1283():58-64. PubMed ID: 19523931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups.
    Takahashi A; Yap JJ; Bohager DZ; Faccidomo S; Clayton T; Cook JM; Miczek KA
    Psychopharmacology (Berl); 2009 May; 204(1):61-71. PubMed ID: 19099296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls.
    Kask K; Bäckström T; Lundgren P; Sundström Poromaa I
    Pharmacol Biochem Behav; 2009 Jun; 92(4):608-13. PubMed ID: 19268499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat.
    Edgar DM; Seidel WF; Gee KW; Lan NC; Field G; Xia H; Hawkinson JE; Wieland S; Carter RB; Wood PL
    J Pharmacol Exp Ther; 1997 Jul; 282(1):420-9. PubMed ID: 9223583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents.
    Wieland S; Belluzzi JD; Stein L; Lan NC
    Psychopharmacology (Berl); 1995 Mar; 118(1):65-71. PubMed ID: 7597124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid modulation of rat pup ultrasonic vocalizations.
    McGregor IS; Dastur FN; McLellan RA; Brown RE
    Eur J Pharmacol; 1996 Oct; 313(1-2):43-9. PubMed ID: 8905327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of neurosteroids on rat behavior and 3H-muscimol binding in the brain.
    Członkowska AI; Sienkiewicz-Jarosz H; Siemiatkowski M; Bidziński A; Płaźnik A
    Pharmacol Biochem Behav; 1999 Aug; 63(4):639-46. PubMed ID: 10462193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of nitric oxide synthase reduces ultrasonic vocalizations of rat pups.
    Podhorna J; Brown RE
    Eur J Pharmacol; 1999 Oct; 382(3):143-50. PubMed ID: 10556664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.
    Brot MD; Akwa Y; Purdy RH; Koob GF; Britton KT
    Eur J Pharmacol; 1997 Apr; 325(1):1-7. PubMed ID: 9151931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of the neuroactive steroid 3 alpha,5 alpha-THDOC on sleep in the rat.
    Müller-Preuss P; Rupprecht R; Lancel M
    Neuroreport; 2002 Mar; 13(4):487-90. PubMed ID: 11930167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flibanserin has anxiolytic effects without locomotor side effects in the infant rat ultrasonic vocalization model of anxiety.
    Podhorna J; Brown RE
    Br J Pharmacol; 2000 Jun; 130(4):739-46. PubMed ID: 10864879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat.
    Rodrìguez-Landa JF; Contreras CM; Bernal-Morales B; Gutièrrez-Garcìa AG; Saavedra M
    J Psychopharmacol; 2007 Jan; 21(1):76-84. PubMed ID: 16533862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term effects of a perinatal exposure to the HBCDD α-isomer in rats: Assessment of early motor and sensory development, spontaneous locomotor activity and anxiety in pups.
    Maurice N; Olry JC; Cariou R; Dervilly-Pinel G; Le Bizec B; Travel A; Jondreville C; Schroeder H
    Neurotoxicol Teratol; 2015; 52(Pt B):170-80. PubMed ID: 26348671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations.
    Kehne JH; McCloskey TC; Baron BM; Chi EM; Harrison BL; Whitten JP; Palfreyman MG
    Eur J Pharmacol; 1991 Feb; 193(3):283-92. PubMed ID: 1675993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ontogenetic changes in responsiveness to benzodiazepine receptor ligands on ultrasonic vocalizations in rat pups.
    Naito H; Nakamura A; Inoue M
    Exp Anim; 1998 Apr; 47(2):89-96. PubMed ID: 9606418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonic vocalizations in rat pups: modulation at the gamma-aminobutyric acidA receptor complex and the neurosteroid recognition site.
    Vivian JA; Barros HM; Manitiu A; Miczek KA
    J Pharmacol Exp Ther; 1997 Jul; 282(1):318-25. PubMed ID: 9223570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors.
    Vanover KE; Rosenzweig-Lipson S; Hawkinson JE; Lan NC; Belluzzi JD; Stein L; Barrett JE; Wood PL; Carter RB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):337-45. PubMed ID: 10991999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
    Ugale RR; Hirani K; Morelli M; Chopde CT
    Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice.
    Rodgers RJ; Johnson NJ
    Pharmacol Biochem Behav; 1998 Jan; 59(1):221-32. PubMed ID: 9443559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior.
    Bleickardt CJ; Mullins DE; Macsweeney CP; Werner BJ; Pond AJ; Guzzi MF; Martin FD; Varty GB; Hodgson RA
    Psychopharmacology (Berl); 2009 Mar; 202(4):711-8. PubMed ID: 18923820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.